Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38)

European Radiology

Volumn 21, Issue 9, 2011, Pages 1988-1995

  Bzyl, Jessica ^a   Lederle, Wiltrud ^a   Rix, Anne ^a   Grouls, Christoph ^a   Tardy, Isabelle ^b   Pochon, Sibylle ^b   Siepmann, Monica ^c   Penzkofer, Tobias ^a   Schneider, Michel ^b   Kiessling, Fabian ^a   Palmowski, Moritz ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Bracco Suisse SA   (Switzerland)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Angiogenesis; Breast cancer; Functional and molecular ultrasound; VEGFR2

Indexed keywords

BR 38; BR 55; ECHO CONTRAST MEDIUM; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; BREAST CANCER; DRUG HALF LIFE; DRUG PROTEIN BINDING; ECHOMAMMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MICROBUBBLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; FLUOROCARBONS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MICROBUBBLES; MOLECULAR BIOLOGY; NEOVASCULARIZATION, PATHOLOGIC; NITROGEN; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS; ULTRASONOGRAPHY, DOPPLER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 80052716472     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2138-y     Document Type: Article

References (35)

1. WA Kaiser 2007 Breast magnetic resonance imaging: principles and techniques Semin Roentgenol 42 228 235 17919525 10.1053/j.ro.2007.07.003 (Pubitemid 47494510)
2. F Kiessling J Huppert M Palmowski 2009 Functional and molecular ultrasound imaging: concepts and contrast agents Curr Med Chem 16 627 642 19199927 10.2174/092986709787458470 1:CAS:528:DC%2BD1MXjsFGqsbg%3D
3. WA Berg JD Blume JB Cormack, et al. 2008 Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer JAMA 299 2151 2163 18477782 10.1001/jama.299.18.2151 1:CAS:528:DC%2BD1cXlvFCnsrY%3D (Pubitemid 351679706)
4. C Balleyguier P Opolon MC Mathieu, et al. 2009 New potential and applications of contrast-enhanced ultrasound of the breast: own investigations and review of the literature Eur J Radiol 69 14 23 18977102 10.1016/j.ejrad. 2008.07.037
5. M Palmowski J Huppert P Hauff, et al. 2008 Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment Cancer Res 68 7042 7049 18757418 10.1158/0008-5472.CAN-08-0285 1:CAS:528:DC%2BD1cXhtVCrs7vO
6. M Palmowski W Lederle J Gaetjens, et al. 2010 Comparison of conventional time-intensity curves vs. maximum intensity over time for post processing of dynamic contrast-enhanced ultrasound Eur J Radiol 75 149 153 10.1016/j.ejrad.2009.10.030
7. AL Klibanov 2005 Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging Bioconjug Chem 16 9 17 15656569 10.1021/bc049898y 1:CAS:528:DC%2BD2cXhtFGgt73M (Pubitemid 40129671)
8. JR Lindner 2004 Microbubbles in medical imaging: current applications and future directions Nat Rev Drug Discov 3 527 532 15173842 10.1038/nrd1417 1:CAS:528:DC%2BD2cXksVaqsrk%3D (Pubitemid 38807535)
9. PA Dayton JJ Rychak 2007 Molecular ultrasound imaging using microbubble contrast agents Front Biosci 12 5124 5142 17569635 10.2741/2553 1:CAS:528:DC%2BD2sXosF2qsb4%3D
10. M Shibuya 2006 Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis J Biochem Mol Biol 39 469 478 17002866 10.5483/BMBRep.2006.39.5.469 1:CAS:528:DC%2BD28XhtFWqsb3M (Pubitemid 44714526)
11. JK Willmann R Paulmurugan K Chen, et al. 2008 US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice Radiology 246 508 518 18180339 10.1148/radiol.2462070536
12. JK Willmann AM Lutz R Paulmurugan 2008 Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo Radiology 248 936 944 18710985 10.1148/radiol.2483072231
13. A Lyshick AC Fleischer J Huamani, et al. 2007 Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography J Ultrasound Med 26 1575 1586 (Pubitemid 351519803)
14. M Palmowski B Morgenstern P Hauff, et al. 2008 Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging Invest Radiol 43 162 169 18301312 10.1097/RLI.0b013e31815a251b 1:CAS:528:DC%2BD1cXisVWht78%3D (Pubitemid 351643142)
15. M Palmowski J Huppert G Ladewig, et al. 2008 Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of anti-angiogenic therapy effects Mol Cancer Ther 7 101 109 18202013 10.1158/1535-7163.MCT-07-0409 1:CAS:528:DC%2BD1cXmsVyhsw%3D%3D
16. JJ Rychak J Graba AM Cheung, et al. 2007 Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis Mol Imaging 6 289 296 18092513 (Pubitemid 350013534)
17. G Korpanty JG Carbon PA Grayburn, et al. 2007 Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clin Cancer Res 13 323 330 17200371 10.1158/1078-0432.CCR-06-1313 1:CAS:528:DC%2BD2sXotlag (Pubitemid 46121886)
18. S Pochon I Tardy P Bussat, et al. 2010 BR55: A lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis Invest Radiol 45 89 95 20027118 10.1097/RLI.0b013e3181c5927c 1:CAS:528:DC%2BC3cXps1SrtA%3D%3D
19. MA Pysz K Foygel J Rosenberg, et al. 2010 Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55) Radiology 256 519 527 20515975 10.1148/radiol.10091858
20. MU Naik TU Naik AT Suckow, et al. 2008 Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion Cancer Res 68 2194 2203 18381425 10.1158/0008-5472.CAN-07-3057 1:CAS:528: DC%2BD1cXktVyqurk%3D (Pubitemid 351521792)
21. C Wang R Navab V Iakovlev, et al. 2007 Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion Mol Cancer Res 5 1031 1039 17951403 10.1158/1541-7786.MCR-06-0391 1:CAS:528:DC%2BD2sXhtFygsLvJ (Pubitemid 350070758)
22. G Kasper M Reule M Tschirschmann, et al. 2007 Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway BMC Cancer 17 7 12
23. A Shrivastava MA von Wronski AK Sato, et al. 2005 A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases Protein Eng Des Sel 18 417 424 16087652 10.1093/protein/gzi049 1:CAS:528: DC%2BD2MXovVOjsro%3D (Pubitemid 41219888)
24. R Pillai ER Marinelli RE Swenson 2006 A Flexible Method for preparation of peptide homo- and heterodimers functionalized with affinity probes, chelating ligands, and latent conjugating groups Biopolymers (Peptide Sci) 84 576 585 10.1002/bip.20570 1:CAS:528:DC%2BD28Xht12hurnN (Pubitemid 44935257)
25. R Pillai ER Marinelli H Fan 2010 A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis Bioconjug Chem 21 556 562 10.1021/bc9005688 1:CAS:528:DC%2BC3cXitFyiu7g%3D
26. R Watanabe M Matsumura T Munemasa, et al. 2007 Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver Invest Radiol 42 643 651 17700280 10.1097/RLI.0b013e31805f2682 1:CAS:528:DC%2BD2sXptVGksb4%3D (Pubitemid 47262933)
27. DR Morel I Schwieger L Hohn, et al. 2000 Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging Invest Radiol 35 80 85 10639039 10.1097/00004424-200001000-00009 1:CAS:528: DC%2BD3cXmsVGgtw%3D%3D (Pubitemid 30033610)
28. JR Lindner PA Dayton MP Coggins 2000 Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles Circulation 102 531 538 10920065 1:STN:280:DC%2BD3czptlKksg%3D%3D (Pubitemid 30639971)
29. KW Ferrara MA Borden H Zhang 2009 Lipid shelled vehicles: engineering for ultrasound molecular imaging and drug delivery Acc Chem Res 42 881 892 19552457 10.1021/ar8002442 1:CAS:528:DC%2BD1MXns1ektLc%3D
30. K Wei AR Jayaweera S Firoozan, et al. 1998 Quantification of myocardial blood flow with ultrasound induced destruction of microbubbles administered as a constant venous infusion Circulation 97 473 483 9490243 1:STN:280: DyaK1c7ktVKrtw%3D%3D (Pubitemid 28090220)
31. M Krix F Kiessling S Vosseler, et al. 2003 Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography Cancer Res 63 8264 8279 14678984 1:CAS:528:DC%2BD3sXpvVagt7s%3D
32. H Shimizu M Miyazaki Y Wakabayashi, et al. 2001 Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats J Hepatol 34 683 689 11434614 10.1016/S0168-8278(00)00055-6 1:CAS:528: DC%2BD3MXkvVKrsr4%3D (Pubitemid 32488783)
33. JK Willmann Z Cheng C Davis, et al. 2008 Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice Radiology 249 212 219 18695212 10.1148/radiol. 2491072050
34. M Dadiani V Kalchenko A Yosepovich 2006 Real-time imaging of lymphangiogenic metastasis in orthotopic human breast cancer Cancer Res 66 8037 8041 16912179 10.1158/0008-5472.CAN-06-0728 1:CAS:528:DC%2BD28XotFWqt7k%3D (Pubitemid 44299168)
35. DJ Hicklin LM Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 1011 1027 15585754 10.1200/JCO.2005.06.081 1:CAS:528:DC%2BD2MXit1Gnsro%3D (Pubitemid 46202320)